Who We Are
Merging AI with molecular biology to reshape the future of medicine.
To merge AI with biotechnology to break traditional drug development boundaries, delivering more precise, effective, and accessible therapies.
Our Mission
We aim to transform targets once considered 'undruggable' into real clinical solutions, rewriting the future of human health through an innovative fusion of AI technology and molecular biology.
Our Vision
"To fundamentally reshape the biological course of illness through precision molecular targeting and AI-enhanced therapeutics, creating a future where diseases once considered untreatable become manageable or curable."
From foundational research to clinical breakthroughs, follow our path as we develop next-generation therapies for fibrosis and oncology.
Looking Ahead: 2026
Anticipated topline results from RECLAIM-HCC Phase 1b/2 trial for Hepatocellular Carcinoma, potentially reshaping treatment options for patients.
Scientific Innovation
Pushing boundaries with AI-enhanced discovery to tackle previously "undruggable" targets.
Patient-Centered Focus
Every research decision is guided by the ultimate goal of improving patient outcomes and quality of life.
Collaborative Excellence
Fostering partnerships across disciplines to accelerate breakthrough discoveries and treatments.
Join Our Mission to Transform Medicine
We're always looking for passionate scientists, engineers, and business professionals to join our team and help us revolutionize drug development through AI.